Cephalexin
- Product NDC
- 42291-007
- 11-digit product format
- 422910007
- Labeler code
- 42291
- Product ID
- 42291-007_563f2702-2b5f-464a-9f1f-9d5a7ac00c2a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cephalexin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AVKARE
- Application
- ANDA062702
- Marketing category
- ANDA
- Marketing start
- 2026-04-24
- Substance
- CEPHALEXIN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062702-001 | CEPHALEXIN | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | |
| A062702-002 | CEPHALEXIN | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A062702-001 | AB |
| A062702-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A062702-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A062702-002 | CEPHALEXIN | EQ 500MG BASE | CAPSULE / ORAL | AB | 1987-02-13 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A062702-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A062702-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062702-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062702-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A062702-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A062702-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062702-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062702-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062702-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062702-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062702-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062702-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062702-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062702-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062702-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062702-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062702-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062702-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A062702-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A062702-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062702-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062702-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062702-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062702-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062702-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062702-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A062702-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A062702-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A062702-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A062702-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A062702-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A062702-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A062702-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A062702-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A062702-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A062702-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A062702-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A062702-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A062702-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A062702-002 | AB | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cephalexin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CEPHALEXIN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| OBN7UDS42Y | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 74f83298-57f7-4166-8dd8-db3e556a68d8 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dfa3f520-409c-432e-b6d3-9250d468c772 | Product name | 1 | 20250401 |
| 64bb7f1a-2c2e-4741-8301-dbfeda7239f6 | Product name | 1 | 20190628 |
| 398aa563-bb78-fe0f-46a8-757c40ef28bf | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42291-007-50 | Cephalexin | 500 in 1 BOTTLE | CAPSULE | 500 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | b73593ce-0b1f-4371-bae1-140742de3b42 | 2026-08-06 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | Unit Dose Solutions, Inc. | 53704ffd-b4f6-8b61-e063-6394a90a01f9 | 2026-06-04 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | Preferred Pharmaceuticals Inc. | ad676021-44f3-4a97-a3dc-28a62fe982bb | 2026-03-25 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | 3fed2817-fc0d-43cd-9f02-948fbc76672c | 2026-03-18 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | AVKARE | 74f83298-57f7-4166-8dd8-db3e556a68d8 | 2025-12-30 | Warnings, Adverse reactions | 062702 ANDA062702 42291-007 |
| Cephalexin | CEPHALEXIN | QPharma Inc | e8b3ece4-cf73-416c-8767-68f425df35f8 | 2025-12-05 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | QPharma Inc | 4e9a8ed3-c490-4a0e-bb29-5eea506f893b | 2025-12-04 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | 6ce11859-aa21-4b3f-bd59-3cd26deca82b | 2025-11-07 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | bff3912c-c39c-40c0-98d2-27c3d506c24d | 2025-10-18 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | ade02343-3e4b-b1f1-e053-2995a90ac5fe | 2024-07-17 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | fc426d0d-9774-4189-8d83-89aa85d926bb | 2024-05-22 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 5b7666f3-4014-45ce-8387-3298d9fe6d25 | 2024-05-07 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 18518154-30ba-48a4-852a-3a7723030071 | 2023-12-07 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | Proficient Rx LP | ada7b8a5-98f4-454c-b38f-92192d4db33f | 2021-08-01 | Warnings, Adverse reactions | 062702 ANDA062702 |
| Cephalexin | CEPHALEXIN | Teva Pharmaceuticals USA, Inc. | 19307ff0-71de-477b-965d-ea243e5ede3a | 2020-12-31 | Warnings, Adverse reactions | 062702 ANDA062702 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 309112 | cephalexin 250 MG Oral Capsule | PSN | 74f83298-57f7-4166-8dd8-db3e556a68d8 | 1 |
| 309114 | cephalexin 500 MG Oral Capsule | PSN | 74f83298-57f7-4166-8dd8-db3e556a68d8 | 1 |
| 309112 | cephalexin 250 MG Oral Capsule | SCD | 74f83298-57f7-4166-8dd8-db3e556a68d8 | 1 |
| 309114 | cephalexin 500 MG Oral Capsule | SCD | 74f83298-57f7-4166-8dd8-db3e556a68d8 | 1 |
| 309114 | cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule | SY | 74f83298-57f7-4166-8dd8-db3e556a68d8 | 1 |
| 309112 | cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule | SY | 74f83298-57f7-4166-8dd8-db3e556a68d8 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 42291-007-50 | 42291000750 | 500 CAPSULE in 1 BOTTLE (42291-007-50) | 500 capsule | 2026-04-24 | No | No | Current |